The most effective way to prevent long COVID is to avoid getting infected in the first place, but vaccination, early treatment, and how you manage the acute illness all meaningfully lower your risk. About 6 in every 100 people who catch COVID develop long-lasting symptoms, and while that number has dropped since the early pandemic years, each reinfection adds another roll of the dice.
Vaccination Lowers Risk by About 23%
Getting vaccinated remains the single best-studied tool for reducing long COVID risk. A large meta-analysis published in Nature Communications found that vaccinated individuals had 23% lower odds of developing long COVID compared to unvaccinated people. Booster doses added further protection: people with a booster had 26% lower odds compared to those who were unvaccinated, and 23% lower odds compared to those who only completed a primary vaccine series.
These numbers reflect averages across many studies and variants. The protection isn’t absolute, but it stacks. Staying current with recommended doses gives you the strongest reduction in risk available from any single intervention.
Antivirals During Acute Infection
If you test positive for COVID, starting antiviral treatment early can reduce your chances of long-term symptoms. A large observational study from the RECOVER Initiative found that people treated with Paxlovid had a 12% lower risk of developing long COVID, with about 3 fewer cases per 100 treated patients. An earlier VA study found a larger effect: a 26% reduction in risk and an absolute risk reduction of roughly 4.5%.
One important caveat: the benefit was not observed in people considered low-risk for severe COVID. If you’re older, immunocompromised, or have chronic health conditions, you’re more likely to benefit from early antiviral treatment. The treatment window is tight, typically within the first five days of symptoms, so testing promptly matters.
Metformin, a widely used diabetes medication, showed a more dramatic 40% reduction in long COVID incidence in a single randomized trial of about 1,100 patients. Participants took a gradually increasing dose over 14 days starting early in their infection. That finding is promising but based on limited data, and nearly half the participants were unvaccinated, making it hard to know how well the effect holds for vaccinated people today.
Each Reinfection Raises the Stakes
Every time you catch COVID, you’re running the risk calculation again. A study published in The Lancet Infectious Diseases found that people with a second infection had roughly double the rate of long COVID diagnoses compared to those with only one infection. The risk ratios for individual symptoms ranged from 1.15 to 3.60 times higher after reinfection.
This means that even after recovering fully from a first bout, you’re not in the clear. Avoiding reinfection through practical measures (good ventilation, masking in crowded indoor spaces during surges, staying home when symptomatic) continues to matter long after your first encounter with the virus.
Rest Aggressively During Acute Illness
One of the more actionable things you can do when you’re sick with COVID is to genuinely rest, not just “take it easy” but deliberately avoid pushing through symptoms. Post-exertional malaise, where symptoms worsen 12 to 48 hours after physical or mental effort and can last days or weeks, is a hallmark feature of long COVID and related conditions like ME/CFS.
During acute illness, this means breaking activities into small segments with planned rest periods between them. If you start feeling dizzy, short of breath, or notice your heart rate climbing, stop what you’re doing and rest. Schedule downtime even when you feel like you’re improving. The temptation to return to normal activity as soon as you feel slightly better is one of the biggest traps. Overdoing it during the acute or early recovery phase can trigger setbacks that become harder to recover from.
Rest proactively before and after any necessary exertion, even routine tasks like showering or preparing meals. This isn’t about being cautious to a fault. It’s about giving your immune system the best possible conditions to clear the virus without triggering the kind of sustained inflammatory response that characterizes long COVID.
Reducing Viral Load Early
Emerging evidence suggests that lowering the amount of virus in your body early in infection may help. A phase 2 randomized trial found that an antihistamine nasal spray (azelastine) reduced SARS-CoV-2 infection rates significantly when used preventively: 2.2% of the spray group became infected compared to 6.7% on placebo. Earlier trials showed the same spray reduced viral load in people already infected.
Saline nasal rinses may also help by physically flushing virus from nasal passages, though the evidence is less robust. The logic is straightforward: less virus replicating in your body means less immune activation and potentially less risk of the persistent inflammation tied to long COVID.
Anti-Inflammatory Nutrition
No specific food or supplement has been proven in a clinical trial to prevent long COVID directly. But the underlying biology is suggestive. Long COVID involves sustained inflammation driven by markers like IL-6 and TNF-alpha, and several dietary patterns are well-documented to lower these same markers.
The Mediterranean diet, rich in vegetables, fruits, whole grains, fish, and olive oil, has the strongest evidence base for reducing systemic inflammation. Specific nutrients with demonstrated anti-inflammatory effects include:
- Omega-3 fatty acids (from fatty fish, flaxseed, or supplements) reduce C-reactive protein and inhibit the production of inflammatory signaling molecules. Studies in patients with acute respiratory distress have shown shorter ICU stays and better blood oxygen levels with omega-3 supplementation.
- Vitamin D dampens the production of pro-inflammatory immune cells. Meta-analyses of COVID patients found that supplementation was associated with less need for intensive care.
- Vitamin C at regular dietary doses is associated with lower levels of inflammatory markers and reduced blood clotting risk in high-risk patients.
- Zinc supports immune cell development, and deficiency increases oxidative stress and inflammatory responses. Supplementation has been linked to fewer respiratory infections and faster recovery.
None of these replace vaccination or antivirals. But maintaining good nutritional status before and during infection gives your immune system better raw materials to work with, and keeping baseline inflammation low may reduce the chance that a COVID infection tips your body into a prolonged inflammatory state.
Who Is at Higher Risk
Some people are more vulnerable to long COVID regardless of what they do. Risk factors that consistently appear in research include older age, female sex, obesity, pre-existing conditions like diabetes or autoimmune disease, and more severe acute illness. Higher levels of spike protein and inflammatory markers in the blood during acute infection correlate with more long COVID symptoms.
If you fall into a higher-risk category, the strategies above become more important, not less. Staying current on vaccines, seeking antiviral treatment quickly when infected, resting thoroughly during illness, and maintaining an anti-inflammatory diet aren’t guarantees, but they represent the strongest evidence-based toolkit currently available for reducing your odds.